News | Artificial Intelligence | December 01, 2022

VIDA Intelligence Portal Embraced by More Than 1,000 Global Sites to Ease Participation in Clinical Trials

Annalise.ai and Nuance announced that the global medical imaging AI company has joined the Nuance Precision Imaging Network (PIN), connecting Annalise.ai workflow orchestration and diagnostic support solutions to over 12,000 healthcare facilities worldwide.

December 1, 2022 —  VIDA Diagnostics, Inc. (VIDA), the leader in imaging intelligence, has announced the availability of VIDA Intelligence Portal 2.0, a major upgrade of its cloud native, AI-enabled Intelligence platform. The newly updated platform drives efficiencies in clinical trial imaging operations by optimizing staff training, image data collection and data quality, curation and management. New digital onboarding features in VIDA Intelligence Portal 2.0 greatly simplify the enrollment process for trial sites. 

"We are thrilled to see sponsors and trial sites across the globe embracing VIDA Intelligence Portal," said Todd Johnson, VIDA CTO. "By empowering new sites to participate in imaging-based clinical trials, we are proud to be extending patient access to novel therapy opportunities. The enhancements to VIDA Intelligence Portal make it easier for sites to become fully certified and operational and to quickly enroll in trials with full confidence in the quality of their image acquisition, staff training and readiness."   

The global network of sites equipped with VIDA Intelligence Portal has expanded to more than 1,000 in less than a year since its release. Hospitals and now imaging centers are engaging with VIDA to participate in clinical trials. Among this group is RAYUS Radiology, a 150-site national provider of advanced diagnostic and interventional radiology. Several other imaging center groups in the United States and Europe have also entered into agreements with VIDA in the last month.   

VIDA has an aggressive roadmap for the VIDA Intelligence Portal, including several new data intelligence services to further accelerate clinical trials. For example, VIDA is well positioned to intelligently identify qualified sites for new trial opportunities.   

Leading this development of VIDA Intelligence Portal is an expert in cloud-based imaging platforms. "I'm passionate about creating innovative, secure cloud products that make our lives better; improving and accelerating clinical trials checks that box for me," said Michel Blaha, VP of Engineering, VIDA, who recently joined the company to lead the evolution of the VIDA Portal. "In my debut at VIDA, I've experienced the passion of this team and, equally important, I've learned how transformative our platform is for customers and for the patients they serve." 

For more information: https://vidalung.ai/connect/ 

Find more RSNA22 coverage here


Related Content

News | Radiology Imaging

Feb. 12, 2026 — Siemens Healthineers and Mayo Clinic are expanding their strategic collaboration to enhance patient care ...

Time February 13, 2026
arrow
News | Digital Pathology

Feb. 11, 2026 — Leica Biosystems has announced the global launch of the Leica CM1950 Cryostat with DualEcoTec Cooling ...

Time February 11, 2026
arrow
Feature | Cardiac Imaging | Kyle Hardner

Advances in coronary CT angiography (CCTA) have reached the point where image quality and AI capabilities are creating ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | PET Imaging

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
Subscribe Now